| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (HEGP 4945 + methicillin-resistant) |
- |
- |
8 － 16 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin)  |
1305 |
| Staphylococcus aureus (HEGP 4945 + methicillin-resistant) |
- |
- |
512 － ? |
Retama raetam (Butanol extract) |
1305 |
| Staphylococcus aureus (HEGP 4945 + methicillin-resistant) |
- |
- |
1250 － ? |
Retama raetam (Ethyl acetate extract) |
1305 |
| Staphylococcus aureus (HEGP 4945 + methicillin-resistant) |
- |
- |
>2000 － ? |
Retama raetam (Methanol extract) |
1305 |
| Staphylococcus aureus (HEGP 8064 + methicillin-susceptible) |
- |
- |
0.38 － 0.75 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1305 |
| Staphylococcus aureus (HEGP 8064 + methicillin-susceptible) |
- |
- |
512 － ? |
Retama raetam (Butanol extract) |
1305 |
| Staphylococcus aureus (HEGP 8064 + methicillin-susceptible) |
- |
- |
1250 － ? |
Retama raetam (Ethyl acetate extract) |
1305 |
| Staphylococcus aureus (HEGP 8064 + methicillin-susceptible) |
- |
- |
>2000 － ? |
Retama raetam (Methanol extract) |
1305 |
| Staphylococcus aureus (HEGP 8213 + methicillin-susceptible) |
- |
- |
0.38 － 0.75 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
1305 |
| Staphylococcus aureus (HEGP 8213 + methicillin-susceptible) |
- |
- |
512 － ? |
Retama raetam (Butanol extract) |
1305 |
| Staphylococcus aureus (HEGP 8213 + methicillin-susceptible) |
- |
- |
1250 － ? |
Retama raetam (Ethyl acetate extract) |
1305 |
| Staphylococcus aureus (HEGP 8213 + methicillin-susceptible) |
- |
- |
>2000 － ? |
Retama raetam (Methanol extract) |
1305 |
| Staphylococcus aureus (Hershey + vancomycin-resistant) |
- |
- |
0.5 － ? |
Daptomycin (Cubicin) |
1034 |
| Staphylococcus aureus (Hershey + vancomycin-resistant) |
- |
- |
1 － ? |
Quinupristin/Dalfopristin (Synercid) |
1034 |
| Staphylococcus aureus (Hershey + vancomycin-resistant) |
- |
- |
4 － ? |
Moxifloxacin (BAY 12-8039, Avelox) |
1034 |
| Staphylococcus aureus (Hershey + vancomycin-resistant) |
- |
- |
32 － ? |
Levofloxacin (Levaquin, Quixin) |
1034 |
| Staphylococcus aureus (Hershey + vancomycin-resistant) |
- |
- |
32 － ? |
Vancomycin (Vancocyn, Lyphocin) |
1034 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
0.25 |
0.5 |
≤0.25 － >4 |
Trimethoprim/Sulfamethoxazole |
1130 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
1 |
1 |
0.5 － 2 |
Quinupristin/Dalfopristin (Synercid) |
1130 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
2 |
2 |
0.5 － 2 |
Linezolid (PNU-100766, U-100766, Zyvox) |
1130 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
>4 |
>4 |
≤0.12 － >4 |
Clindamycin (Cleocin) |
1130 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
>4 |
>4 |
4 － >4 |
Levofloxacin (Levaquin, Quixin) |
1130 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
>4 |
>4 |
>4 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1130 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
>16 |
>16 |
0.06 － >16 |
Solithromycin (CEM-101 and OP-1068) |
1130 |
| Staphylococcus aureus (heterogeneous + vancomycin-intermediate) |
>16 |
>16 |
0.25 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
1130 |
| Staphylococcus aureus (HIP5836 + glycopeptide-intermediate + New Jersey) |
- |
- |
0.5 － ? |
A-80915A |
1001 |
| Staphylococcus aureus (HIP5836 + glycopeptide-intermediate + New Jersey) |
- |
- |
1 － ? |
A-80915B |
1001 |
| Staphylococcus aureus (HK 4 + erythromycin-susceptible + methicillin-resistant) |
- |
- |
1 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
289 |